CAMKK2 and cardiac hypertrophy: Furthermore, cardiac-specific inhibition of CaMKK2 worsens cardiac hypertrophy induced by transverse aortic binding accompanied by reduced AMPK and PGC-1α levels and mitochondrial biogenesis (Watanabe et al, 2014).